SEC Filing Summary: National Health Investors Inc (NHI)
Business Context and Reporting Period
This Form 8-K, dated May 5, 2025, serves as a current report for National Health Investors Inc, a Maryland corporation. The filing primarily functions to disclose supplemental information for the quarter ended March 31, 2025, pursuant to Regulation FD (Item 7.01). The company's common stock trades on the New York Stock Exchange under the symbol NHI.
Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within "Supplemental Information" (Exhibit 99.1) and the company's website, but the figures are not present in the body of this 8-K document.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document acts as a conduit to direct investors to external supplemental data rather than reporting specific operational changes or comparative period analysis.
Guidance, Outlook, and Risks
The filing does not include management commentary, forward-looking guidance, risk factors, or contingencies. It strictly references the availability of supplemental information for the first quarter of 2025.
Key Facts for Investor Verification
- Verify the specific financial metrics for the quarter ended March 31, 2025, by accessing Exhibit 99.1 or the company website (www.nhireit.com) as referenced in Item 7.01.
- Confirm the date of the report is May 5, 2025, and the reporting period covers the first quarter of 2025.
- Note that this filing is a regulatory disclosure mechanism and does not contain the underlying financial data within its text.